Or. Admin. Code § 855-041-7050 - Definitions - Long Term Care Pharmacy
As used in OAR 855-041-7000 through 855-041-7080:
(1) "Long term care facility" means a
facility with permanent facilities that include inpatient beds, providing
medical services, including nursing services but excluding surgical procedures
except as may be permitted by the rules of the director, to provide treatment
for two or more unrelated patients. "Long Term Care facility" includes skilled
nursing facilities and intermediate care facilities but may not be construed to
include facilities licensed and operated pursuant to ORS
443.400 to
443.455.
(2) For the purposes of Schedule II
prescriptions in 21 CFR
1306.11 (04/01/2023),
21 CFR
1306.12 (04/01/2023),
21 CFR
1306.13 (04/01/2023),
21 CFR
1306.14 (04/01/2023), and
21 CFR
1306.15 (04/01/2023), the DEA definition of
"long term care facility" as defined in
21 CFR
1300.01 (04/01/2023) includes
"community-based care facilities."
(3) "Community Based Care Facility" means a
home, facility or supervised living environment licensed or certified or
otherwise recognized by an agency of the state of Oregon which provides 24-hour
care, supervision, and assistance with medication administration. These include
but are not limited to Adult Foster Homes, Residential Care Facilities (RCF),
Assisted Living Facilities (ALF), Intermediate Care Facilities for Individuals
with Intellectual Disabilities and Inpatient Hospice.
(4) "Pharmaceutical Care" means the
responsible provision of any or all of the following services by the
pharmacist:
(a) Develop and maintain policies
and procedures for pharmaceutical services;
(b) Provide direction and oversight regarding
all aspects of the acquisition, disposition, handling, storage, and
administration of drugs including but not limited to the following:
(A) Receipt and interpretation of physician's
orders;
(B) Ordering and receiving
of medications;
(C) Handling of
emergency drugs and supplies;
(D)
Labeling of all drugs;
(E)
Selection of drug delivery systems;
(F) Development of systems to provide timely
delivery of drugs and supplies;
(G)
Monitoring of drug storage conditions and expiration dates;
(H) Monitoring accuracy and efficiency of
medication administration and compliance with physician's orders;
(I) Establishing and monitoring of
appropriate record keeping;
(J)
Accountability of controlled substances;
(K) Return, release, and/or destruction of
discontinued or outdated drugs; and
(L) Compliance with state and federal laws
and regulations related to pharmaceutical services and medication
management.
(c) Provide
training and in-service education to facility staff;
(d) Perform drug regimen review for each
resident on a regularly scheduled basis for the purpose of promoting
therapeutic appropriateness and achieving the desired drug therapy outcomes by
identifying issues such as:
(A)
Over-utilization or underutilization;
(B) Therapeutic duplication;
(C) Drug-disease contraindications;
(D) Drug-drug interactions;
(E) Incorrect drug, drug dosage or duration
of drug treatment;
(F) Drug-allergy
interaction;
(G) Clinical
abuse/misuse;
(H) Untreated
indication;
(I) Monitoring and
assessing of drug therapy outcomes;
(e) Communicate effectively with residents'
physicians and facility staff; and
(f) Participate in resident care
planning.
Notes
Publications: Publications referenced are available for review at the agency.
Statutory/Other Authority: ORS 689.205
Statutes/Other Implemented: ORS 689.305
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.